Stay updated with breaking news from Upstream Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- DelveInsight's 'Asthma Pipeline Insight – 2023' report provides comprehensive global coverage of available, marketed, and pipeline asthma...
Asthma is a chronic disease that affects a substantial number of patients worldwide, including children, a number of pharmaceutical companies are involved in developing drugs for asthma. This
/PRNewswire/ -- BioSpace, the leading life sciences news and careers site, has announced its 2023 selections for the industry's most promising up-and-coming...
Upstream Bio has initiated a phase 1b study of UPB-101 in asthma patients with the dosing of the first patient.